平成29年度 アジア諸国医薬品・医療機器規制情報収集・分析 …
ACTD（The ASEAN Common Technical Dossier for the Registration of Pharmaceuticals for Human Use）は、上記取り組みを 踏まえてASEAN諸国で合意され、2009年1月から施行された、ASEAN諸国の行政庁に「ヒト用医薬品」の薬事申請を行う際の、申請様式のガイド
Download 平成29年度 アジア諸国医薬品・医療機器規制情報収集・分析 …
Information
Domain:
Source:
Link to this page:
Documents from same domain
339 - pmda.go.jp
www.pmda.go.jp医薬品・医療機器等安全性情報 No.339 −3− 2016年12月 1 ミルナシプラン塩酸塩，デュロキセチン塩酸塩 及びベンラファキシン塩酸塩製剤の自動車運転等
Report on the Deliberation Results - pmda.go.jp
www.pmda.go.jpReport on the Deliberation Results . December 3, 2014 . Evaluation and Licensing Division, Pharmaceutical and Food Safety Bureau . Ministry of Health, Labour and Welfare
Filgrastim, Lenograstim, Nartograstim, Pegfilgrastim
www.pmda.go.jpPharmaceuticals and Medical Devices Agency This English version is intended to be a reference material for the convenience of users. In the event of
Pharmaceuticals and Medical Devices Safety …
www.pmda.go.jpPharmaceuticals and Medical Devices Safety Information No. 347 - 3 - October 2017 Abbreviations ADR Adverse drug reaction Alb Albumin ALP Alkaline phosphatase
The Ministry of Health, Labour and Welfare …
www.pmda.go.jpThe Ministry of Health, Labour and Welfare Ministerial Notification No. 519 Pursuant to Paragraph 1, Article 41 of the Pharmaceutical AŠairs Law (Law No.
2018.3 No. 267 - pmda.go.jp
www.pmda.go.jp1 2018. 3. dsu no. 267 重 要 生薬 510 サンシシ 2 漢方製剤 520 茵蔯蒿湯 3 温清飲 4 黄連解毒湯 3 加味帰脾湯 4
PMDA HP
www.pmda.go.jp後発医薬品品質情報 no.9 4 独立行政法人医薬品医療機器総合機構（pmda）では、本誌情報やジェネリック医薬品品質情報検討会の
PMDAからの医薬品適正使用のお願い - pmda.go.jp
www.pmda.go.jp医薬品医療機器総合機構PMDA. からの医薬品適正使用のお願い http://www.pmda.go.jp/safety/info-services/drugs/0001.html
IMPURITIES GUIDELINE FOR RESIDUAL S Q3C(R5)
www.pmda.go.jpinternational conference on harmonisation of technical requirements for registration of pharmaceuticals for human use ich harmonised tripartite guideline impurities: guideline for …
2.7.2 summary of clinical pharmacology Studies
www.pmda.go.jpCONFIDENTIAL RM2003/00379/00 2.7.2 Summary of Clinical Pharmacology 4 ABBREVIATIONS 3TC lamivudine (EPIVIRƒ) ABC abacavir (ZIAGENƒ)AE Adverse Event AUC0-t,ss Area under the drug concentration-time curve from 0 to time t at steady state AUC∞ Area under the plasma concentration versus time curve from time 0 and …
Related documents
DRUG REGISTRATION GUIDANCE DOCUMENT (DRGD)
www.npra.gov.myACTD ASEAN Common Technical Dossier ACTR ASEAN Common Technical Requirement AMV Analytical Method Validation ANOVA Analysis of Variance API Active Pharmaceutical Ingredient (Interchangeable with drug substance or active substance). ASEAN Association of Southeast Asian Nations ATC Anatomical Therapeutic Chemical ...
Guide to Application for Registration of Medicinal Products
moh.gov.bn3.3 Registration Dossier 3.31 All applications for medicinal product registration are to be made by submission of the required documents which are in line with the ASEAN Common Technical Dossier (ACTD) for the registration of pharmaceuticals for human use and ASEAN Common Technical Requirements (ACTR).
ACTD ASEAN COMMON TECHNICAL DOSSIER
asean.orgThis ASEAN Common Technical Dossier (ACTD) is a guideline of the agreed upon common format for the preparation of a well-structured Common Technical Dossier (CTD) applications that will be submitted to ASEAN regulatory authorities for …
PHILIPPINE VARIATION GUIDELINES
www.fda.gov.phClinical documents as per ASEAN Common Technical Dossier (ACTD) part IV (where applicable). 8 MaV-2 Change of content of product labeling C 1. Product labeling refers to Package Insert (PI), Patient Information Leaflet (PIL), unit carton label, inner label and/or blister strips. 2. The change is not a minor variation and not within the scope of ...
Overview on ASEAN Guideline on PV Requirements
www.npra.gov.mythe effect that the same pre-approval dossier pertaining to process validation that have been submitted to the reference regulatory agency are submitted to DRA for evaluation. Under certain circumstances where validation documents may ... The …